FDA just posted briefing documents for its expert panel discussing the J&J Covid shot Friday.
— Sarah Owermohle (@owermohle) February 24, 2021
This is the first clear breakdown I've seen of efficacy in areas w/ variant spread, but shows efficacy building over time: pic.twitter.com/YReI2QkvZa